Practice Therapeutics Ivacaftor for cystic fibrosis BMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k1783 (Published 17 May 2018) Cite this as: BMJ 2018;361:k1783 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Efficacy and safety of tranexamic acid in acute haemorrhage BMJ January 04, 2024, 384 e075720; DOI: https://doi.org/10.1136/bmj-2023-075720 Vitamin B12 BMJ November 20, 2023, 383 e071725; DOI: https://doi.org/10.1136/bmj-2022-071725 Two-drug antiretroviral regimens for HIV BMJ September 01, 2023, 382 e071079; DOI: https://doi.org/10.1136/bmj-2022-071079 Continuous glucose monitoring BMJ March 03, 2023, 380 e072420; DOI: https://doi.org/10.1136/bmj-2022-072420 Treatments for poorly controlled asthma BMJ October 04, 2021, 375 n2355; DOI: https://doi.org/10.1136/bmj.n2355
